Methods for Protein Purification
Polysorbate 20 is used to prevent protein precipitation in purification methods, enhancing yield and purity by stabilizing solutions during chromatography, addressing the inefficiencies of existing techniques.
Patent Information
- Application Number
- JP2024534558
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-12-08
- Filing Date
- 2022-12-07
- Publication Date
- 2024-11-26
AI Technical Summary
Existing protein purification methods, particularly affinity chromatography, are prone to precipitation events that reduce yield and purity, and optimization protocols often exacerbate these issues.
The use of polysorbate 20 (PS20) is introduced to prevent protein precipitation by optimizing the solvation potential of solutions, specifically through controlled addition and incubation, thereby maintaining proteins in solution during purification processes.
Polysorbate 20 effectively minimizes precipitation, enhancing the yield and purity of proteins during purification by maintaining solubility and reducing non-specific binding, thus improving the efficiency of chromatography processes.
Smart Images

Figure 2024544029000001 
Figure 2024544029000002 
Figure 2024544029000003
Abstract
Description
[Technical field]
[0001] The present invention provides methods for use in protein purification. The disclosed methods help avoid precipitation events and can be used to improve the performance and / or efficiency of protein purification protocols. The methods may find particular application in affinity chromatography. [Background technology]
[0002] Proteins and peptides for use in medicines are often prepared from recombinant systems. In such cases, useful proteins or peptides often need to be purified and / or extracted from complex mixtures. Highly accurate and reliable methods of purification are required to ensure that the target proteins and peptides can be purified to suitable yields and purity.
[0003] Specific (or target) proteins or peptides can be purified using many different well-known techniques. Affinity chromatography is one example of a particularly accurate, reliable and precise method to extract specific target proteins / peptides to high purity. However, the efficiency and performance of these techniques are easily blunted by precipitation events.
[0004] The present disclosure aims to provide methods and techniques that can be used to minimize precipitation events and thus improve the yield and purity of purified proteins. Summary of the Invention [Means for solving the problem]
[0005] The present disclosure provides methods that may improve or prepare solutions for use in protein purification and / or protein extraction processes.
[0006] For the avoidance of doubt, a solution may contain a solvent and a solute; the solute component may include one or more proteins or peptides. Thus, the methods described herein may be applied to solutions containing proteins or peptides.
[0007] For convenience, as used herein, the term "protein" should be construed to also encompass shorter molecules, which may alternatively be referred to as "peptides." Thus, a solution containing a protein may, for example, contain one or more proteins and / or peptides.
[0008] Solutions, particularly those containing proteins, are susceptible or prone to precipitation events. For example, precipitation can occur when the solvation potential of the solvent components of the solution changes. Without wishing to be bound by theory, the change in solvation potential can make the solute (e.g., protein and / or peptide) less soluble, leading to precipitation of some of the solute.
[0009] The addition of one or more reagents to a solution can change the solvation potential of the solution. Additionally or alternatively, changes to the pH, temperature and / or composition of the solution can also change its solvation potential.
[0010] In view of the above, precipitation of proteins from solution may occur in response to the addition of reagents and / or changes to the pH, temperature and / or composition of the solution.
[0011] The methods described herein may be applied to a solution containing one or more proteins for purification or extraction. Hereinafter, the term "purification" is used to describe all protein / peptide purification and / or extraction processes / events.
[0012] One or more proteins for purification may be referred to as "target proteins". It should be understood that the term "target protein" refers to any protein (or peptide) that is to be selectively extracted and / or purified from a solution. Any given target protein may be purified or extracted from a simple or complex mixture of other solutes, such as other proteins. For example, one or more target proteins may be purified or extracted from a solution containing a homogenous or heterogenous mix of proteins.
[0013] The amount of target protein present in the solution may vary. For example, any of the solutions described herein (including, for example, any of the loading solutions described below) may contain between about 0.01 mg / ml protein and 0.50 mg / ml of any given target protein. For example, solutions of the present disclosure may contain between about 0.02 mg / mL, 0.03 mg / mL, 0.04 mg / mL, 0.05 mg / mL, 0.06 mg / mL, 0.07 mg / mL, 0.08 mg / mL, 0.09 mg / mL, 0.10 mg / mL, 0.11 mg / mL, 0.12 mg / mL, 0.125 mg / mL, 0.13 mg / mL, 0.14 mg / mL, 0.15 mg / mL, 0.16 mg / mL, 0.17 mg / mL, 0.18 mg / mL, 0.19 mg / mL, 0.20 mg / mL, 0.21 mg / mL, 0.22 mg / mL, 0.23 mg / mL, 0.24 mg / mL, 0.25 mg / mL, 0.26 mg / mL, 0.27 mg / mL, 0.28 mg / mL, 0.29 mg / mL, 0.30 mg / mL, 0.31 mg / mL, 0.32 mg / mL, 0.33 mg / mL, 0.34 mg / mL, 0.35 mg / mL, 0.36 mg / mL, 0.37 mg / mL, 0.38 mg / mL, 0.39 mg / mL, 0.40 mg / mL, 0.41 mg / mL, 0.42 mg / mL, 0.43 mg / mL, 0.44 mg / mL, 0.45 mg / mL, 0.46 mg / mL, 0.47 mg / mL, 0.48 mg / mL, 0. , 0.175mg / ml, 0.18mg / ml, 0.19mg / ml, 0.20mg / ml, 0.25mg / ml, 0.25mg / ml, 0.275mg / ml, 0.30mg / ml, 0.325mg / ml, 0.35mg / ml, 0.375mg / ml, 0.40mg / ml, 0.425mg / ml, 0.45mg / ml, or about 0.475mg / ml of any particular target protein. For example, the disclosed solution may contain about 0.07 to about 0.138mg / ml of target protein. In one teaching, the disclosed solution may contain about 0.09mg / ml of target protein.
[0014] The total protein content of the solution (i.e., the total amount of all proteins in the solution of the present disclosure (including any target protein)) may also vary and may be within the range of about 0.5 to about 2 mg / ml, such as about 0.6 mg / ml, 0.7 mg / ml, 0.8 mg / ml, 0.9 mg / ml, 1.0 mg / ml, 1.1 mg / ml, 1.2 mg / ml, 1.3 mg / ml, 1.4 mg / ml, 1.5 mg / ml, 1.6 mg / ml, 1.7 mg / ml, 1.8 mg / ml, or 1.9 mg / ml. The total protein content may be between about 0.7 and 1.8 mg / ml. In one embodiment, the total protein content may be 1.3 mg / ml.
[0015] Proteins may be extracted or purified from a solution (including a solution containing a heterogeneous or homogeneous mix of proteins) by a number of different techniques. For example, proteins may be purified or extracted using size exclusion chromatography, hydrophobic interaction chromatography, ion exchange chromatography, free-flow electrophoresis, affinity chromatography, and high performance liquid chromatography (HPLC).
[0016] For example, affinity chromatography is a separation technique based on the interaction between target proteins and ligands. Typically, affinity chromatography utilizes a resin or matrix that is coupled to a ligand specific for one or more target proteins. The ligand may be, for example, an antibody or a lectin. Affinity purification techniques tend to be highly specific, but are also prone to non-specific binding events and clogging through precipitated solutes; this reduces the overall efficiency of the process and the purity of the output.
[0017] The methods described herein can be applied to solutions intended to be used in protein purification procedures, such as chromatography or affinity chromatography processes. For example, the solution of interest in the methods described herein may contain one or more target proteins and may be intended to be loaded onto an affinity chromatography column. This type of solution may be referred to as a "loading solution."
[0018] The loading solution from which one or more target proteins are to be extracted or purified may also require optimization, for example, to reduce problems associated with non-specific binding (such as may occur between non-target solutes in the loading solution and the (affinity) matrix of a chromatography column) and solute precipitation, including target protein precipitation. Those skilled in the art will recognize that optimization of the loading solution may maximize protein yield and purity and / or ensure that a chosen purification / extraction process functions properly.
[0019] For the avoidance of doubt, the term "protein yield" refers to the amount of target protein obtained from a purification or extraction procedure. Many factors affect the yield; for example, if the loading solution exhibits precipitation of one or more solutes, the yield may be lower than expected.
[0020] The term "purity" refers to the level of contaminants in any of the fractions obtained. Fractions containing one or more target proteins should contain as low a level of contaminants as possible. Non-target solutes, such as non-target proteins, may be an example of unwanted contaminants. Pure or substantially pure fractions may contain low or undetectable levels of contaminants. The methods described herein may be used to help reduce the level of contaminants in any given fraction, particularly fractions containing target proteins.
[0021] In view of the above, an efficient protein purification process is one that yields sufficient quantities of a target protein of purity with acceptable levels of contaminants.
[0022] The solution from which one or more target proteins are to be extracted or purified may require optimization before being fed into the purification procedure; any optimization is necessary to ensure that the purification procedure selected results in suitable yield and purity of the target proteins.
[0023] The optimization protocol may include, for example, adjusting the composition and / or pH of the solution before it is fed into a selected purification procedure.
[0024] In some cases, the optimization protocol itself may induce protein precipitation. In other words, the parameters that ensure optimal performance of the purification / extraction procedure and purity and yield are sometimes in conflict with the parameters that minimize non-specific binding events and solute (including target protein) precipitation. In fact, protein precipitation sometimes occurs as a result of the protocol used (and is necessary) to optimize the loading solution.
[0025] The methods provided by the present disclosure allow a solution containing a target protein to be optimized for use in a purification process, while at the same time reducing or minimizing the risk of that optimization process leading to solute (i.e., target protein) precipitation.
[0026] Furthermore, the methods described herein allow the loading solution to be optimized for maximum efficiency, purity and yield in the purification procedure while avoiding precipitation events associated with prior art optimization techniques.
[0027] Those skilled in the art will recognize that any method that allows the loading solution to be optimized but reduces the risk of solute precipitation will help increase the target protein yield, the purity of its output, and the service life of the purification equipment (e.g., purification columns).
[0028] Without wishing to be bound by theory, these advantages arise because the methods described herein help keep proteins in solution, which prevents clogging of equipment such as columns used in chromatography and affinity chromatography procedures, as well as reducing non-specific binding.
[0029] Thus, in a first aspect, there is provided a method for preventing precipitation in a solution, said method comprising contacting the solution with an amount of polysorbate.
[0030] The term "polysorbate" may include all members of the relevant class of oil-based liquid emulsifiers derived from ethoxylated sorbitan (a derivative of sorbitol) esterified with fatty acids. The term polysorbate may further include polysorbate 20 (PS20), polysorbate 40 (PS40), polysorbate 60 (PS60) and polysorbate 80 (PS80). The term "polysorbate" may include, for example, compounds known under the trade names Kolliphor, Scattics, Alkest, Canarcel and Tween.
[0031] In a further aspect, a method for preventing precipitation in a solution is provided, the method comprising contacting the solution with an amount of Polysorbate 20 (PS20).
[0032] A solution may contain one or more solutes.
[0033] The solute may include one or more proteins.
[0034] The solute may contain one or more target proteins - ie, proteins to be extracted or purified from a solution.
[0035] One or more solutes, such as one or more proteins (including potentially one or more target proteins), precipitate from solution under certain conditions. The methods described herein can be used to prevent, reduce or inhibit precipitation of solutes from solution. Indeed, the methods described herein may be used to prevent, reduce or inhibit precipitation of solutes from solution under conditions that would normally be expected to induce precipitation.
[0036] The solution may be a loading solution. Thus, the methods described herein may be used to prevent precipitation from a loading solution, the methods comprising contacting the loading solution with an amount of polysorbate, such as polysorbate 20 (PS20).
[0037] For example, the disclosed methods may be used to prevent precipitation of one or more proteins from a loading solution and / or to prevent precipitation of one or more target proteins from a loading solution. This type of method may include contacting the loading solution with an amount of polysorbate, such as polysorbate 20 (PS20). Furthermore, the methods may prevent or reduce precipitation events even when the solution, such as the loading solution, is optimized for use in a chromatography or affinity chromatography process.
[0038] However, polysorbates (including PS20) generate radicals that can increase the oxidation of target proteins for purification. Selection of specific polysorbate concentrations and / or incubation times has now been shown to lower the risk of such oxidative events.
[0039] The polysorbate (e.g., polysorbate 20) may be added to a solution, e.g., a loading solution, such that the final concentration of the polysorbate (e.g., polysorbate 20) in the solution is between about 0.1% and 5% (% w / v). For example, the polysorbate (including polysorbate 20) may be added to a solution, e.g., a loading solution, such that the final concentration of the polysorbate (e.g., polysorbate 20) in the solution is between about 0.2%, about 0.3%, about 0.4%, about 0.5%, about 0.6%, about 0.7%, about 0.8%, about 0.9%, about 1.0%, about 1.1%, about 1.2%, about 1.3%, about 1.4%, about 1.5%, about 1.6%, about 1.7%, about 1.8%, about 1.9%, about 2%, about 2.1%, about 2.2%, about 2.3%. , about 2.4%, about 2.5%, about 2.6%, about 2.7%, about 2.8%, about 2.9%, 3.0%, about 3.1%, about 3.2%, about 3.3%, about 3.4%, about 3.5%, about 3.6%, about 3.7%, about 3.8%, about 3.9%, about 4.0%, about 4.1%, about 4.2%, about 4.3%, about 4.4%, about 4.5%, about 4.6%, about 4.7%, about 4.8% and about 4.9% (all concentrations are in % w / v).
[0040] In the context of this disclosure, the term "about" may mean ±0.05% (% w / v) of the final concentration of polysorbate / polysorbate 20 (in solution).
[0041] The methods described herein may use polysorbate / polysorbate 20 at a final concentration (in solution) of 0.1%, 0.25%, 0.5%, 0.75% or 1.0% (% w / v).
[0042] Once the polysorbate (including polysorbate 20) is added to the solution, the polysorbate or PS20 / solution mix is incubated at a suitable temperature for a predetermined period of time.
[0043] The polysorbate or PS20 / solution mix may be incubated anywhere between about 1 minute and 2 hours. For example, the PS20 / solution mix may be incubated for about 5 minutes, about 10 minutes, about 15 minutes, about 20 minutes, about 30 minutes, about 40 minutes, about 50 minutes, about 70 minutes, about 80 minutes, about 90 minutes, about 100 minutes, about 110 minutes, or about 115 minutes. With respect to the length of incubation time, the term "about" may mean ±5 minutes. For example, the polysorbate or PS20 / solution mix may be incubated anywhere between 15 and 25 minutes (e.g., 20 minutes).
[0044] The polysorbate or PS20 / solution mix may be incubated at any temperature between about 10° C. and 30° C. For example, the polysorbate or PS20 / solution mix may be incubated at a temperature of about 11° C., about 12° C., about 13° C., about 14° C., about 15° C., about 16° C., about 17° C., about 18° C., about 19° C., about 20° C., about 21° C., about 22° C., about 23° C., about 24° C., about 25° C., about 26° C., about 27° C., about 28° C., or about 29° C. With respect to incubation temperature, the term about may mean ±2° C. The polysorbate or PS20 / solution mix may be incubated at any temperature between about 21° C. and 25° C. (e.g., 23° C.).
[0045] Polysorbate or polysorbate 20 may be added to the solution or loading solution to a final concentration of 0.5% (% w / v) and the polysorbate or polysorbate 20 / (loading) solution mix may be incubated at 23° C.±2° C. for 20±5 minutes.
[0046] As mentioned above, the solution, e.g. the loading solution, may be subjected to some optimization protocol before the solution is subjected to a purification (e.g. chromatography) process. The parameters selected for optimization may have some effect on the efficiency and / or yield of the target protein from the protein / peptide purification process (into which the loading solution is fed). Indeed, the associated changes in one or more parameters of the optimization protocol and solution may lead to protein aggregation and / or aggregation and eventual precipitation in the loading solution.
[0047] The pH of the loading solution may be altered so that the pH is optimal for the affinity purification process. A pH that is optimal for a protein purification process may be suboptimal for the solubility of some or all of the proteins in the loading solution, including some or all of the target protein. Thus, altering the pH as part of an optimization protocol may have the effect of causing precipitation of one or more proteins or peptides in the loading solution.
[0048] The optimal pH of a solution (or loading solution) for use in a protein purification procedure, such as a chromatography-based purification procedure, may vary depending on the nature of the solution, the protein to be purified and / or the details of the protein purification procedure to be used. For example, the optimal pH may be approximately pH 4, pH 4.5, pH 5, pH 5.5, pH 6, pH 6.5, pH 7, pH 7.5, pH 8, pH 8.5, pH 9 or pH 9.5. Thus, optimization may include adjusting (e.g., by titration) the solution from one pH (e.g., a suboptimal pH) to another optimal pH.
[0049] The conductivity of a solution, e.g., a loading solution, may also be altered so that the conductivity is optimal for the affinity purification process. Conductivity refers to the electrical conductivity of a solution and is reported in units of millisiemens (mS). A conductivity that is optimal for a protein purification process may be suboptimal for the solubility of some or all of the proteins in the loading solution, including some or all of the target proteins. Thus, altering the conductivity as part of an optimization protocol may have the effect of causing precipitation of one or more proteins or peptides in the loading solution.
[0050] The optimal conductivity of a solution (or loading solution) for use in a protein purification procedure, such as a chromatographic-based purification procedure, may vary depending on the nature of the solution, the protein to be purified, and / or the details of the protein purification procedure to be used. For example, the optimal conductivity may be approximately 8±2 mS / cm, 9±2 mS / cm, 10±2 mS / cm, 12±2 mS / cm, 14±2 mS / cm, 16±2 mS / cm, 18±2 mS / cm, 20±2 mS / cm, 22±2 mS / cm, or 24±2 mS / cm. Thus, optimization may include adjusting a solution from one conductivity (e.g., a suboptimal conductivity) to another optimal conductivity.
[0051] While changing the pH and / or conductivity of a solution (e.g., a loading solution) separately may result in some level of protein / peptide precipitation, the effect of changing both pH and conductivity together may be significant and more of the proteins and / or peptides in solution may precipitate.
[0052] In view of the above, there is provided a method for preventing precipitation of proteins in a loading solution, the method comprising contacting the loading solution with an amount of polysorbate. Further provided is a method for preventing precipitation of proteins in a loading solution, the method comprising contacting the loading solution with an amount of polysorbate 20 (PS20).
[0053] It should be noted that the term "preventing" may encompass any reduction in instances of precipitation from a challenge solution relative to the rate or amount of precipitation from a challenge solution that has not been subjected to the methods of the present disclosure (i.e., not contacted with polysorbate / polysorbate 20 (PS20)).
[0054] The loading solution (to which a certain amount of polysorbate or PS20 is added) may be optimized for the affinity chromatography process.
[0055] For example, the pH of the loading solution may need to be optimized.
[0056] Additionally or alternatively, the conductivity of the loading solution may need to be optimized.
[0057] The disclosed methods may ensure that at least the target protein or peptide remains fully or partially in solution immediately prior to use of the loading solution in a protein purification process, such as an affinity chromatography process.
[0058] It should be noted that a solution to be subjected to the methods of the present disclosure, e.g., a loading solution, may be contacted with an amount of polysorbate or polysorbate 20 (PS20; amounts as described above) before, during or after the optimization protocol is (or will be) applied to the solution. The methods of the present disclosure may further include contacting the solution with an amount of polysorbate / PS20 before the solution is applied or subjected to a purification process.
[0059] Accordingly, the present disclosure provides a method for preventing precipitation of a target protein in a loading solution upon optimization of the loading solution for use in a protein purification protocol, the method comprising contacting the loading solution with an amount of polysorbate or polysorbate 20 (PS20) and then optimizing the loading solution for use in the protein purification protocol.
[0060] A method for preventing target protein precipitation in a loading solution upon optimization of the loading solution for use in a protein purification protocol may include contacting the loading solution with polysorbate or polysorbate 20 (PS20) to a final concentration of any of the concentrations mentioned above. For example, the loading solution may be contacted with polysorbate or PS20 at a final concentration of 0.5% (% w / v), and the loading solution may then be optimized for use in the protein purification protocol.
[0061] The step of contacting the loading solution with polysorbate or PS20 (e.g., PS20 to a final concentration of 0.5% (% w / v)) may further include incubating the polysorbate or PS20 / loading solution mix at a suitable temperature for a period of time to prevent protein (e.g., target protein) precipitation from the loading solution. Suitable incubation times and temperatures are described above and apply herein. For example, the polysorbate or PS20 / loading solution mix may be incubated at 23° C.±2° C. for 20±5 minutes.
[0062] Any of the disclosed methods may find application in methods for purifying glycoproteins. That is, the methods for preventing protein precipitation described herein may be applied to a solution containing a glycoprotein, which is for purification from the solution. The disclosed methods may be used to prevent (reduce or inhibit) precipitation of the glycoprotein from the solution.
[0063] In some cases, the loading solution may contain one or more glycoproteins. Indeed, one or more of the glycoproteins in the loading solution may be a (or the) target protein. That is, the loading solution may contain one or more glycoproteins that are to be purified from the loading solution, for example by chromatography-based techniques.
[0064] The term "glycoprotein" may include proteins known as gonadotropins. For example, the term "glycoprotein" may include follicle stimulating hormone (FSH), human chorionic gonadotropin (hCG), and luteinizing hormone (LH). Many glycoproteins, including gonadotropins, are used in therapeutic treatments. For example, gonadotropins (such as FSH, LH, and hCG) are used in the treatment of infertility.
[0065] It should be noted that the terms "glycoprotein", "FSH" and "hCG" encompass all isoforms and / or recombinant or naturally occurring forms thereof. The glycoprotein may be a recombinant glycoprotein, such as, for example, recombinant FSH, recombinant hCG or recombinant LH produced in a host cell. The glycoprotein may be provided in the form of a solution from which it will be purified or extracted by affinity chromatography.
[0066] In view of the above, the methods described herein may be applied to a solution, e.g. a loading solution, comprising one or more proteins selected from the group consisting of: (i) glycoproteins; (ii) FSH; (iii) recombinant FSH (rFSH); (iv) hCG; and (v) recombinant hCG (rhCG); One or more proteins (selected from the group consisting of proteins (i)-(v) above) are to be purified from the solution or loading solution.
[0067] The proteins / glycoproteins may be from urine.
[0068] Glycoproteins may be present (in a solution, e.g., a loading solution) as a single isoform or as a mixture of isoforms, as is well known in the art. Thus, the solution (or loading solution) to be subjected to a method for purifying or extracting a target protein may, for example, contain a quantity of recombinant FSH or a naturally occurring form of FSH (e.g., FSH is present as a single isoform or as a mixture of isoforms).
[0069] The glycoprotein component of the solution may be one example of a target protein to be extracted and at risk of precipitation.
[0070] Thus, the present disclosure provides a method for preventing glycoprotein precipitation from a solution, the method comprising contacting a solution containing the glycoprotein with an amount of polysorbate or polysorbate 20 (PS20).
[0071] In addition, the disclosure provides a method for preventing glycoprotein precipitation from a solution upon optimization of the solution for use in a glycoprotein purification protocol, the method comprising contacting a solution containing a glycoprotein with an amount of polysorbate or polysorbate 20 (PS20) and then optimizing the solution for use in a procedure to purify the glycoprotein.
[0072] As mentioned above, optimization of a solution containing a glycoprotein may induce precipitation of that glycoprotein from the solution. To minimize the risk of an "optimization-induced precipitation" event, a solution containing a glycoprotein for purification may include contacting the solution with polysorbate or polysorbate 20 (PS20) to a final concentration of any of the concentrations mentioned above. For example, the solution may be contacted with polysorbate or PS20 to a final concentration of 0.5% (% w / v), and the solution may then (or simultaneously) be optimized for use in a protein purification protocol. The step of contacting the solution with polysorbate or PS20 (e.g., PS20 to a final concentration of 0.5% (% w / v)) may further include incubating the polysorbate or PS20 / solution mix at a suitable temperature for a period of time to prevent glycoprotein precipitation from the solution. Suitable incubation times and temperatures are mentioned above and apply herein. For example, the polysorbate or PS20 / solution mix may be incubated for 20±5 minutes at 23° C.±2° C. The solution may then be optimized if necessary and then fed into (or used in) a protein purification procedure.
[0073] Optimization of a glycoprotein-containing solution for use in a procedure for purifying one or more glycoproteins therein may include adjusting the pH and / or conductivity of the solution.
[0074] For example, the pH of a solution (e.g., a loading solution) may be altered so that the pH is optimal for affinity purification of the glycoprotein solute. A pH that is optimal for a glycoprotein purification process may be suboptimal for the solubility of some or all of the proteins, including glycoproteins, in the solution / loading solution. Thus, altering the pH as part of an optimization protocol may have the effect of causing precipitation of one or more glycoproteins (and / or other proteins or peptides) in the solution / loading solution.
[0075] The optimal pH of a solution (or loading solution) for use in a protein purification procedure, such as a chromatographic-based purification procedure, may vary depending on the nature of the solution, the glycoprotein to be purified, and / or the details of the glycoprotein purification procedure to be used. For example, for purification of FSH and / or hCG from a solution (e.g., loading solution), the optimal pH may be approximately pH 4, pH 4.5, pH 5, pH 5.5, pH 6, pH 6.5, pH 7, pH 7.5, pH 8, pH 8.5, pH 9, or pH 9.5. In one teaching, the optimal pH may be pH 8. Thus, optimization may include adjusting (e.g., by titration) a solution containing a glycoprotein for purification from one pH (e.g., a suboptimal pH) to another optimal pH.
[0076] The conductivity of the solution may also be varied so that the conductivity is optimal for affinity purification of the glycoprotein solutes (as discussed above, the term "conductivity" refers to the electrical conductivity of the solution and is reported in units of millisiemens (mS)). A conductivity that is optimal for a glycoprotein purification process may be suboptimal for the solubility of some or all of the proteins (including glycoproteins) in the solution (or loading solution). Thus, it may be necessary to vary the conductivity of the solution to ensure that the conductivity is optimal for a selected glycoprotein optimization process, but that optimization may have the effect of causing precipitation of one or more glycoproteins (or any of the other protein solutes).
[0077] The optimal conductivity of a solution (or loading solution) for use in a glycoprotein purification procedure, such as a chromatographic-based purification procedure, may vary depending on the nature of the solution, the glycoprotein to be purified, and / or the details of the protein purification procedure to be used. For example, the optimal conductivity may be approximately 8±2mS / cm, 9±2mS / cm, 10±2mS / cm, 12±2mS / cm, 14±2mS / cm, 16±2mS / cm, 18±2mS / cm, 20±2mS / cm, 22±2mS / cm, or 24±2mS / cm. In one teaching, the optimal conductivity may be 16±2mS / cm. Thus, optimization may include adjusting the solution from one conductivity (e.g., a suboptimal conductivity) to another optimal conductivity.
[0078] Although changing the pH and / or conductivity of a solution containing glycoproteins for purification (e.g., a loading solution) separately can result in some level of glycoprotein precipitation, the effect of changing both pH and conductivity together can be significant and more glycoproteins in solution can precipitate.
[0079] Where the glycoprotein is FSH and / or hCG (i.e. the solution contains FSH and / or hCG for purification), the optimal pH may be approximately pH 8 and the optimal conductivity may be approximately 16±2 mS / cm. Prior to optimization, the solution from which the glycoprotein, e.g. FSH and / or hCG, is to be purified may have a suboptimal pH (higher or lower than pH 8) and / or conductivity (higher or lower than 16±2 mS / cm).
[0080] The properties and composition of the solution, e.g., the loading solution, that contains the glycoprotein for purification and / or extraction and that will be subjected to the methods of the present disclosure may vary depending on the source of the glycoprotein, and therefore the number and type of optimization required will also vary.
[0081] If the glycoprotein is recombinant and produced or produced in a cell, a method for obtaining a solution or loading solution comprising the recombinant glycoprotein (e.g. recombinant FSH and / or hCG) may comprise providing cells capable of expressing the recombinant glycoprotein to be purified, culturing the cells in a suitable medium and then inducing expression of the recombinant glycoprotein. The expressed glycoprotein may then be collected from the cells (via a lysate prepared from the cells) and / or from the medium (e.g. collecting the recombinant protein from the cell culture supernatant, e.g. by centrifugation). In this case, the solution or loading solution may comprise or be derived from the culture medium.
[0082] Suitable methods for culturing transfected cells and inducing expression of a heterologous nucleic acid (or vector) therein are known, and further information may be obtained, for example, from 'Production of Recombinant Proteins: Novel Microbial and Eukaryotic Expression Systems': Edited by Prof. Dr. Gerd Gellissen; Pub. Wiley (2004).
[0083] Any suitable host cell may be used for the production of recombinant proteins, and the recombinant glycoproteins described herein may be produced using, for example, mammalian cells. Suitable mammalian cells (or cell lines) may include, for example, CHO cells, PER.C6® cells (information regarding PER.C6® cells is disclosed in PCT / EP2016 / 064668 (published as WO 2016 / 207353)), HEK293 cells, HT1080 cells, COS cells, NOS cells, SP20 cells, and the like.
[0084] The cell line may be cultured under suitable conditions in a suitable medium and the target protein (eg, a glycoprotein) may be collected from the cells or from the culture medium.
[0085] The cell lysate and / or culture medium may be subjected to a clarification or filtration protocol. This type of protocol may use, for example, a depth filter. The clarification or filtration protocol may help to remove or remove contaminants that may affect downstream processes. For example, the clarification and / or filtration process may help to remove host cell proteins (HCPs), DNA, possible lipids, colloids, cell debris, endotoxins and other substances from the cell culture medium. The clarification or filtration step may further help to protect membranes used in downstream filtration processes that may be required to produce a useful load solution.
[0086] The filtered and / or clarified cell lysate / culture medium may then be further processed to enrich for any target protein content. The enrichment step may be achieved through the use of an ultrafiltration step designed to further remove other low molecular weight components (components that are less than <10 Kda) from the filtered and / or clarified cell lysate culture medium. The ultrafiltration process may be used to remove pigments and the like.
[0087] Those skilled in the art will recognize that non-target protein content in the loading solution, including, for example, any low molecular weight compounds or dyes, can adversely affect protein purification or extraction processes, particularly affinity chromatography-based processes.
[0088] The filtered / clarified and ultrafiltered cell culture medium may (optionally) be subjected to a sterilization procedure. For example, the filtered / clarified and ultrafiltered cell culture medium may be filtered to remove contaminants. The filtered / clarified and ultrafiltered cell culture medium may be passed through a 0.2 μm filter.
[0089] The concentration of the target protein (e.g., rFSH or rhCG) may be, for example, 0.05-2.0 mg / ml. For example, the concentration of the target protein may be about 0.06 mg / ml, 0.07 mg / ml, 0.08 mg / ml, 0.09 mg / ml, 0.1 mg / ml, 0.2 mg / ml, 0.3 mg / ml, 0.4 mg / ml, 0.5 mg / ml, 0.6 mg / ml, 0.7 mg / ml, 0.8 mg / ml, 0.9 mg / ml, 1.0 mg / ml, 1.1 mg / ml, 1.2 mg / ml, 1.3 mg / ml, 1.4 mg / ml, 1.5 mg / ml, 1.6 mg / ml, 1.7 mg / ml, 1.8 mg / ml, or about 1.9 mg / ml. The target protein concentration may be between about 0.4 and 1.5 mg / mL.
[0090] The total protein concentration may be about 1.0 mg / ml, 1.5 mg / ml, 1.75 mg / ml, 2.0 mg / ml, 2.25 mg / ml, 2.5 mg / ml, 2.75 mg / ml, 3.0 mg / ml, 3.25 mg / ml, 3.5 mg / ml, 3.75 mg / ml or 4.0 mg / ml. The filtered / clarified and ultrafiltered cell culture medium (optionally sterilized as described above) may contain or be supplemented with additional buffers and / or additives. For example, the filtered / clarified and ultrafiltered cell culture medium may contain or be supplemented with glycine (e.g., 100 mM glycine) and / or NaCl (e.g., 50 mM NaCl). The filtered / clarified and ultrafiltered cell culture medium may have a pH of about 9.0±0.2 and a conductivity of about 6±1 mS / cm, or about 7±1 mS / cm, or about 8±1 mS / cm, or about 9±1 mS / cm, or about 10±1 mS / cm.
[0091] Filtered / clarified and ultrafiltered cell culture medium (which may optionally be sterilized as described above) may be used to prepare the loading solution.
[0092] The loading solution may be prepared by combining a volume of the filtered / clarified and ultrafiltered cell culture medium described above (optionally sterilized) with a volume of another "loading stock solution."
[0093] The loading stock solution may, for example, include certain additives, diluents and / or buffers. For example, the loading stock solution may include an amount of Tris and NaCl. For example, the loading stock solution may include 0.8M Tris and 3M NaCl. The loading stock solution may have a pH of about 8.3, for example pH 8.3±0.2. The loading stock solution may have a conductivity of about 164 mS / cm, for example 164±2 mS / cm.
[0094] A volume, for example 40 ml, of the loading stock solution may be added per liter of the (optionally sterilized) filtered / clarified and ultrafiltered cell culture medium described above to provide a combined solution that is the loading solution. The pH of the resulting loading solution may be adjusted, for example, to pH 8.0±0.2 with 1 M HCl. The conductivity of the loading solution may be 16±2 mS / cm. The solution / loading solution prepared and containing the glycoprotein for purification may be optimized so that the loading solution may be used in a process designed to purify the target (recombinant) glycoprotein. As mentioned above, the act of optimizing this type of loading solution (by adjusting one or more parameters of the solution) may induce protein precipitation (including glycoprotein precipitation) that may adversely affect the yield and purity of the protein purification procedure. The methods described herein may contact the solution or loading solution with an amount of PS20 (before, during or after the optimization protocol) to prevent, inhibit and / or reduce those precipitation events.
[0095] It should be noted that the pH and / or conductivity of any solution or loading solution, including those containing (recombinant) glycoproteins for purification, may be determined and any optimization (bringing the pH and / or conductivity within acceptable optimal parameters) may be applied. Prior to meeting any determined optimization requirements, the solution may be contacted with a quantity of PS20 to minimize the risk of optimization-induced precipitation events.
[0096] In view of the above, a method for purifying or extracting a recombinant protein may comprise: Obtaining or providing a solution comprising a recombinant protein; adding polysorbate or polysorbate 20 to the solution; and Loading the solution onto an affinity chromatography column designed to purify or extract the recombinant protein.
[0097] The recombinant protein may be recombinant FSH or recombinant hCG.
[0098] The method may further include determining the pH and / or conductivity of the solution. If the pH and / or conductivity of the solution is determined to be suboptimal, an amount of polysorbate or PS20 may be added and the solution may then be optimized to have an optimal pH and / or conductivity.
[0099] Methods for producing recombinant glycoproteins, including, for example, recombinant FSH and recombinant hCG, are described in WO2009 / 127826, WO2013 / 020996, WO2016207353 and WO2011042688, the entire contents of all of which are incorporated herein by reference. In that these methods use protein purification procedures, such as chromatography and / or affinity chromatography procedures, to extract recombinant FSH and / or hCG, any loading solution to be used may be subject to the methods of the present invention. For example, the loading solution may be contacted with the disclosed amount of PS20 so that the loading solution can be optimized for use in the purification procedure and the risk that the optimization procedure will induce (FSH and / or hCG) precipitation events can be minimized.
[0100] Disclosed herein is a method for preventing, reducing or inhibiting optimization-induced precipitation of FSH and / or hCG from a solution, the method comprising contacting the solution with an amount of PS20, the amount of PS20 being sufficient to keep the FSH and / or hCG in solution throughout the optimization protocol.
[0101] Those skilled in the art will recognize that the purified protein may be present in one or more fractions collected from the chromatography process. The amount of target protein in any particular fraction may vary, and some fractions may contain more target protein than others. To increase the amount of target protein recovered, fractions may be pooled. The collected and / or pooled fractions may be subject to additional purification and / or concentration protocols.
[0102] Fractions obtained from a protein purification process (e.g., an affinity chromatography process) may be further processed by pooling to combine fractions containing the target protein and / or to increase the concentration of the target protein. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0103] The invention will now be illustrated by the following examples. EXAMPLES
[0104] Example 1 PS20 optimization experiments to achieve optimal conditions Prior to demonstrating that QS chromatography has the ability to remove potential enveloped viruses, there is a step dedicated to inactivating enveloped viruses, where Harvest-AD is supplemented with PS20 to a final concentration of 1% (%w / v) followed by incubation at 23±2°C for 1 hour. Note that the term "Harvest-AD" generally encompasses material collected from protein purification / extraction protocols. This material may include a loading solution (loading solution containing one or more target proteins for purification / extraction) as defined herein. In one embodiment, "Harvest-AD" is the material output from any ultrafiltration / diafiltration step, and the term "AD" refers to "post-diafiltration".
[0105] PS20 as a solubilizer: For example, an affinity load (or "loading solution") containing rhCG may be loaded at pH 8 and with a conductivity of 16±2 mS / cm. The low conductivity may allow non-specific proteins to bind to the resin and block binding sites for rhCG; if that non-specific binding is irreversible, a decrease in rhCG capacity or yield will occur over time.
[0106] From Harvest-AD, Affinity-Load may be prepared at pH 9.0 and with a conductivity of approximately 5 mS / cm.
[0107] Setting the pH of Harvest-AD to 8.0 without PS20 (e.g., to a final concentration of 1% (% w / v)) and raising the conductivity to 16±2 mS / cm (=Affinity-Load) resulted in protein precipitation (see results below).
[0108] When PS20 was added to Harvest-AD to a final concentration of 1% (% w / v) before pH & conductivity adjustment and incubated for 1 hour at 23±2° C., there was no precipitation, so PS20 helps prevent protein precipitation in affinity loading.
[0109] Experiments were performed to find the minimal PS20 concentration required to obtain a stabilized affinity load (pH 8.0 & 16 ± 2 mS / cm).
[0110] After finding that addition of PS20 to a final concentration of 0.5% (% w / v) yielded a stable affinity load, the incubation time was reduced from 1 h to 20 min without producing any precipitation in the affinity load (data not shown).
[0111] However, PS20 generates radicals that can increase target protein oxidation (in this example, oxidation of rhCG), therefore, lowering the concentration of PS20 and the incubation time reduces the risk of such oxidative events.
[0112] Experiments showed that PS20 to a final concentration of 0.5% (% w / v) and an incubation time / temperature of 20±5 min, 23±2°C helped reduce precipitation of target proteins (e.g., rhCG) from the loading solution and reduced the risk of oxidation events caused by the addition of PS20.
[0113] [Table 1]
[0114] [Table 2]
[0115] [Table 3]
[0116] The final process for the preparation of the affinity load is as follows. At the end of the PS20 treatment (0.5% PS20, incubated at 23±2°C with stirring for 20±5 min), 40 mL of solution [0.8 M Tris, 3 M NaCl pH 8.3±0.2, 164±2 mS / cm] is added per liter of Harvest-AD and the pH is adjusted to 8.0±0.2 with 1 M HCl. Verify that the conductivity obtained during affinity loading is within 16 ± 2 mS / cm (the volume of 0.8 M Tris, 3 M NaCl solution added is designed to achieve this conductivity range)
[0117] [Table 4]
[0118] [Table 5]
[0119] [Table 6]
[0120] [Table 7]
[0121] [Table 8]
[0122] Refining Run H-AD was volumetrically concentrated by an average of 50-fold by UF1 (min-max range between 37-66-fold), with rhCG-containing Harvest containing an average rhCG concentration of 0.8 mg / mL (min-max range between 0.4-1.5 mg / mL) and an average total protein concentration (by Bradford) of 3 mg / mL (min-max range between 2-5 mg / mL).
[0123] H-AD diluent consisted of 100 mM glycine, 50 mM NaCl pH 9.0±0.2, 6±1 mS / cm [finally changed to 100 mM glycine, 50 mM NaCl with similar pH and conductivity].
[0124] Preparation of loading solution After PS20 treatment (0.5% PS20, incubated at 23±2° C. with stirring for 20±5 min), 40 mL of a solution containing 0.8 M Tris, 3 M NaCl pH 8.3±0.2, 164±2 mS / cm is added per 1 L of Harvest-AD. The pH is adjusted to 8.0±0.2 with 1 M HCl. Ensure that the conductivity obtained in the affinity load solution is within 16±2 mS / cm (the volume of added 0.8 M Tris, 3 M NaCl solution is designed to be within this conductivity range).
[0125] [Table 9]
[0126] [Table 10]
[0127] Example 5 For the preparation of rFSH, the processes and techniques developed for the preparation of rhCG were applied.
[0128] rFSH harvest using 0.5% or 1% (% w / v) PS20 yielded a clear solution (no precipitate). -Volumetrically based, they are on average 39-fold concentrated (min-max range is between 34-47-fold) with an average rFSH concentration of 0.09 mg / mL (min-max range is between 0.07-0.138 mg / mL). Mean total protein concentration of 1.3 mg / mL (min-max range between 0.7-1.8 mg / mL) (according to Bradford). ·H-AD diluent consists of 100mM glycine, 60mM NaCl pH 9.0±0.2, 9.0±0.5mS / cm.
[0129] The invention is further described by reference to the following numbered paragraphs: 1. A method for preventing protein precipitation from a solution, said method comprising contacting the solution with an amount of Polysorbate 20 (PS20). 2. A method for preventing protein precipitation from a solution, said method comprising contacting the solution with an amount of polysorbate. 3. The method according to item 2, wherein the polysorbate is selected from the group consisting of polysorbate 20 (PS20); polysorbate 40 (PS40); polysorbate 60 (PS60); and polysorbate 80 (PS80). 4. The method of any one of paragraphs 1 to 3, wherein the solution is for use in or by a protein purification process. 5. The method according to any one of items 1 to 4, wherein the solution is a loading solution for use in a protein purification process. 6. The method according to items 4 to 5, wherein the protein purification process includes affinity chromatography. 7. The method according to any one of items 1 to 6, wherein the solution contains one or more proteins selected from the group consisting of: (i) a glycoprotein or recombinant glycoprotein; (iii) FSH or recombinant FSH; and (iv) hCG or recombinant hCG. 8. The method according to any one of items 1 to 7, wherein the protein purification process is for the purification of a protein selected from the group consisting of: (i) a glycoprotein or recombinant glycoprotein; (iii) FSH or recombinant FSH; and (iv) hCG or recombinant hCG. 9. The method according to any one of paragraphs 1 and 4 to 8, wherein the amount of PS20 is an amount that produces a final concentration of PS20 in the solution of between about 0.1% (% w / v) and 5% (% w / v). 10. The method according to any one of paragraphs 1 and 4 to 9, wherein the amount of PS20 is an amount that yields a final concentration of PS20 in the solution of 0.5% (% w / v). 11. The method according to any one of items 1 and 4 to 10, wherein the PS20 is contacted with the solution for anywhere from about 1 minute to 2 hours. 12. The method according to any one of items 1 and 4 to 11, wherein the PS20 is contacted with the solution for 15 to 25 minutes. 13. The method according to any one of items 1 and 4 to 12, wherein the PS20 is contacted with the solution at a temperature between about 10°C and 30°C. 14. The method according to any one of items 1 and 4 to 13, wherein the PS20 is contacted with the solution at a temperature between about 21°C and 25°C. 15. The method of any one of paragraphs 1 and 4 to 14, wherein after contact with PS20, the solution or loading solution is optimized for use with a protein purification process. 16. The method of claim 15, wherein optimizing the solution or loading solution includes adjusting the pH and / or conductivity. 17. The method according to claim 15 or 16, wherein the solution is prepared at pH 8 and with a conductivity between 14 and 18 mS / cm. 18. The method according to any one of items 1 to 17, wherein the solution is derived from a cell culture medium. 19. The method of paragraph 18, wherein host cell proteins, DNA, potential lipids, colloids, cell debris and / or endotoxins are removed from the solution derived from the cell culture medium prior to contact with PS20. 20. A method for preventing protein precipitation during optimization of a loading solution for affinity chromatography, the method comprising: contacting a loading solution to be optimized for affinity chromatography with an amount of PS20 to provide a PS20 / loading solution; and Optimizing the PS20 / loading solution mix for affinity chromatography The method includes: 21. The method of claim 20, wherein the amount of PS20 contacted with the loading solution produces a loading solution having a final concentration of PS20 between about 0.1% (% w / v) and 5%. 22. The method of claim 20 or 21, wherein the PS20 / loading solution mix is incubated for any period between 15 and 25 minutes and at a temperature between 21°C and 25°C. 23. The method according to any one of items 20 to 22, wherein the loading solution is derived from a cell culture medium and contains a recombinant glycoprotein. 24. The method according to any one of items 20 to 23, wherein the loading solution is derived from a cell culture medium and contains recombinant FSH or recombinant hCG. 25. A method for preparing a loading solution for use with an affinity chromatography process; the method comprising contacting a loading solution with a quantity of PS20 to provide a PS20 / loading solution mix. 26. The method of claim 25, wherein the PS20 / loading solution mix contains between 0.1% and 5% (% w / v) PS20. 27. The method of claim 25 or 26, wherein the PS20 / solution mix is incubated for any period between 15 and 25 minutes and at a temperature between 21°C and 25°C. 28. The method according to any one of items 25 to 27, wherein the loading solution is derived from a cell culture medium and contains a recombinant glycoprotein. 29. The method according to any one of items 25 to 28, wherein the loading solution is derived from a cell culture medium and contains recombinant FSH or recombinant hCG. 30. The method of any one of paragraphs 25 to 29, wherein after contact with PS20, the loading solution is optimized for use by a protein purification process. 31. The method of claim 30, wherein optimizing the loading solution includes adjusting the pH and / or conductivity of the loading solution. 32. The method according to any one of items 30 to 31, wherein the loading solution is prepared at pH 8 and with a conductivity of 14 to 18 mS / cm. 33. A method for purifying a protein, the method comprising: (a) obtaining or providing a solution containing the protein to be purified; (b) contacting the solution with an amount of PS20; and (c) purifying the protein from the solution. 34. The method according to claim 33, wherein the protein to be purified is a protein selected from the group consisting of: (i) a glycoprotein or recombinant glycoprotein; (ii) FSH or recombinant FSH; and (iii) hCG or recombinant hCG. 35. The method of claim 33 or 34, wherein the solution is derived from a cell culture medium. 36. The method of claim 35, wherein the solution is clarified and / or filtered prior to contacting with PS20. 37. The method of claim 36, wherein host cell proteins, DNA, potential lipids and colloids, cell debris and endotoxins are removed from the solution prior to contacting the solution with PS20. 38. The method of any one of clauses 33 to 37, wherein the protein is purified by affinity chromatography. 39. The method of any one of clauses 33 to 38, wherein the purified protein is eluted and recovered. 40. The method of claim 39, wherein the eluted and recovered protein is not treated with a combination of caprylic acid and ethanol. 41. The method of any one of clauses 39 and 40, wherein the eluted and recovered protein is not filtered using a glass fiber filter. 42. The method according to any one of clauses 39 to 41, wherein the eluted and recovered proteins are not subjected to sulfopropyl sepharose chromatography and / or hydrophobic interaction chromatography.
Claims
1. 1. A method for preventing protein precipitation from a loading solution, the method comprising contacting the solution with an amount of polysorbate 20 (PS20).
2. 10. The method of claim 1, wherein the loading solution is for use with a protein purification process.
3. The method according to claim 1 or 2, wherein the loading solution is an affinity chromatography loading solution.
4. The method comprises: (i) a glycoprotein or a recombinant glycoprotein; (iii) FSH or recombinant FSH; and (iv) hCG or recombinant hCG The method according to any one of claims 1 to 3, which is a method for preventing precipitation from a solution of one or more proteins selected from the group consisting of:
5. 5. The method of any one of claims 1 to 4, wherein the amount of PS20 is an amount that yields a final concentration of PS20 in the solution of between about 0.1% (% w / v) and 5% (% w / v), optionally wherein the amount of PS20 is an amount that yields a final concentration of PS20 in the solution of 0.5% (% w / v).
6. 6. The method of any one of claims 1 to 5, wherein the PS 20 is contacted with the solution for anywhere from about 1 minute to 2 hours, optionally the PS 20 is contacted with the solution for 15 to 25 minutes.
7. 7. The method of any one of claims 1 to 6, wherein the PS 20 is contacted with the solution at a temperature anywhere between about 10°C and 30°C, and optionally, the PS 20 is contacted with the solution at a temperature anywhere between about 21°C and 25°C.
8. The method of any one of claims 1 to 7, wherein the solution is contacted with PS20 to a final concentration of 0.5% (% w / v) at 23±2°C for 20±5 minutes.
9. 9. The method of any one of claims 1 to 8, wherein after contact with PS20, the solution is optimized for use with a protein purification process, and optionally the solution is prepared at pH 8 and with a conductivity between 14-18 mS / cm.
10. 1. A method for preventing protein precipitation during optimization of a loading solution for affinity chromatography, the method comprising: contacting a loading solution to be optimized for affinity chromatography with an amount of PS20 to provide a PS20 / loading solution; and Optimizing the PS20 / loading solution mix for affinity chromatography The method includes:
11. The method of claim 10, wherein the amount of PS20 contacted with the loading solution produces a loading solution having a final concentration of PS20 of between about 0.1% (% w / v) and 5% (% w / v).
12. 12. The method of claim 10 or 11, wherein the PS20 / loading solution mix is incubated for anywhere from 15 to 25 minutes and at a temperature between 21°C and 25°C.
13. The method of any one of claims 10 to 12, wherein the loading solution comprises recombinant FSH or recombinant hCG.
14. 1. A method for purifying a protein, the method comprising: (a) obtaining or providing a solution containing the protein to be purified; (b) contacting the solution with an amount of PS20; and (c) purifying the protein from the solution. The method includes:
15. The protein to be purified may be: (i) a glycoprotein or a recombinant glycoprotein; (ii) FSH or recombinant FSH; and (iii) hCG or recombinant hCG The method of claim 14, wherein the protein is selected from the group consisting of:
16. 16. The method of claim 14 or 15, wherein the method comprises contacting the solution with PS20 to a final concentration of 0.5% (% w / v) at 23±2° C. for 20±5 minutes.
Citation Information
Patent Citations
Methods for Purifying fsh or fsh Mutants
JP2009518361A
Method for producing recombinant human fsh
JP2011172602A
Compositions and methods containing alkyl glycosides for stabilizing protein-containing formulations
JP2013533244A
Methods of Purification and / or Viral Inactivation
JP2018521049A
Manufacturing process of annexin V
JP2018534250A
